COM:CORBUSPHARMA
Corbus Pharmaceuticals Holdings, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Pharmaceuticalswebsite
corbuspharma.comipo date
Oct 27, 2014
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibod...Show More